Ticker Details
Taysha Gene Therapies, Inc.
IPO Date:	September 24, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.86B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.29 | 4.71%
Avg Daily Range (30 D):	$0.21 | 3.50%
Avg Daily Range (90 D):	$0.20 | 3.58%

Institutional Daily Volume
Avg Daily Volume:	1.72M
Avg Daily Volume (30 D):	2.42M
Avg Daily Volume (90 D):	2.36M

Trade Size
Avg Trade Size (Sh.):	195
Avg Trade Size (Sh.) (30 D):	110
Avg Trade Size (Sh.) (90 D):	118

Institutional Trades
Total Institutional Trades:	736
Avg Institutional Trade:	$2.02M
Avg Institutional Trade (30 D):	$3.16M
Avg Institutional Trade (90 D):	$2.37M
Avg Institutional Trade Volume:	.52M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.56M
Avg Closing Trade (30 D):	$4.19M
Avg Closing Trade (90 D):	$2.97M
Avg Closing Volume:	588.44K

News

Jun 25, 2026 @ 2:33 AM Taysha Gene Therapies Announces Pricing of Public ... Source: Na

Apr 29, 2026 @ 12:00 PM Taysha Gene Therapies to Release First Quarter 202... Source: Not Specified

Apr 3, 2026 @ 12:00 PM Taysha Gene Therapies Announces Inducement Grant U... Source: Na

Mar 19, 2026 @ 12:00 PM Taysha Gene Therapies Reports Full-Year 2025 Finan... Source: Not Specified

Feb 6, 2026 @ 1:00 PM Taysha Gene Therapies Announces Inducement Grant U... Source: Na

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.38	$-.12	$-.08
Diluted EPS	$-.38	$-.12	$-.08
Revenue	$7.47M	$M	$5.49M
Gross Profit
Net Income / Loss	$-129.88M	$-42.41M	$-27.85M
Operating Income / Loss	$-132.56M	$-43.49M	$-28.3M
Cost of Revenue
Net Cash Flow	$160.15M	$-43.19M	$22.59M
PE Ratio